Neurocrine Biosciences, Inc.

NASDAQ:NBIX  
95.55
+0.43 (+0.45%)
Other Pre-Announcement

Neurocrine Biosciences Reports Q3 Loss Per Share $0.62

Published: 11/09/2020 21:59 GMT
Neurocrine Biosciences Inc (NBIX) - Neurocrine Biosciences Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.62.
Q3 Non-GAAP Earnings per Share $0.97.
Q3 Earnings per Share Estimate $0.22 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Total Revenue $258.5 Million Versus $222.1 Million.
Q3 Revenue View $283.0 Million -- Refinitiv Ibes Data (analyst estimates).